A formulation containing sa-mRNA coding for S-protein from the D614G and Omicron BA.4/5 variants also demonstrated higher neutralising antibody responses with greater breadth against different COVID-19 strains compared with a bivalent conventional mRNA vaccine.13 This evidence concerns the gene PROS1 and COVID-19.